Glycopeptide Antibiotic Teicoplanin Inhibits Cell Entry of SARS-CoV-2 by Suppressing the Proteolytic Activity of Cathepsin L

Since the outbreak of the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), public health worldwide has been greatly threatened. The development of an effective treatment for this infection is crucial and urgent but is hampered by the incompl...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Fei, Pan, Ting, Huang, Feng, Ying, Ruosu, Liu, Jun, Fan, Huimin, Zhang, Junsong, Liu, Weiwei, Lin, Yingtong, Yuan, Yaochang, Yang, Tao, Li, Rong, Zhang, Xu, Lv, Xi, Chen, Qianyu, Liang, Anqi, Zou, Fan, Liu, Bingfeng, Hu, Fengyu, Tang, Xiaoping, Li, Linghua, Deng, Kai, He, Xin, Zhang, Hui, Zhang, Yiwen, Ma, Xiancai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096618/
https://www.ncbi.nlm.nih.gov/pubmed/35572668
http://dx.doi.org/10.3389/fmicb.2022.884034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096618/
https://www.ncbi.nlm.nih.gov/pubmed/35572668
http://dx.doi.org/10.3389/fmicb.2022.884034

Ejemplares similares